Jennison Associates
PBYI icon

Jennison Associates’s Puma Biotechnology PBYI Stock Holding History

Jennison Associates’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-488,418
Closed -$22.4M – 695
2018
Q3 		$22.4M Sell
488,418
-462,580
-49% -$22.3M 0.02% 382
2018
Q2 		$56.3M Buy
950,998
+465,453
+96% +$27M 0.05% 248
2018
Q1 		$33M Buy
+485,545
New +$36.4M 0.03% 323
2014
Q3 		– Sell
-214,547
Closed -$14.2M – 743
2014
Q2 		$14.2M Sell
214,547
-215,061
-50% -$15.3M 0.01% 457
2014
Q1 		$44.7M Buy
429,608
+19,943
+5% +$2.34M 0.04% 342
2013
Q4 		$42.4M Sell
409,665
-321,846
-44% -$18.9M 0.04% 340
2013
Q3 		$39.3M Sell
731,511
-183,585
-20% -$9.9M 0.04% 344
2013
Q2 		$40.6M Buy
+915,096
New +$32.3M 0.05% 322

Other funds holding PBYI

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return